Tourmaline Bio, Inc.
TRMLDelisted Oct 28, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827506
Tourmaline Bio, Inc. was delisted on Oct 28, 2025; its insiders filed their last Form 4 on Oct 28, 2025; 134 institutions reported holding it in 13F filings for Q3 2025, worth $1.03B in total; no superinvestor held it.
Q2 2024 vs. Q1 2024
How the institutions holding Tourmaline Bio, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 96 | 1 | 84 | −11 |
| Shares | 20.6M | 18.7K | 21.2M | +613.3K (+3.0%) |
| Value | $469.9M | $428.6K | $272.0M | −$197.4M (−42.1%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Tourmaline Bio, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ra Capital Management, L.P. | 2,538,925 | $32.7M | 0.43% |
| Eversept Partners, LP | 204,781 | $2.63M | 0.20% |
| Nuveen Asset Management, LLC | 79,845 | $1.03M | 0.00% |
| Walleye Capital LLC | 78,907 | $1.01M | 0.01% |
| DAFNA Capital Management LLC | 75,982 | $977.1K | 0.23% |
| Bank of New York Mellon Corp | 70,697 | $909.2K | 0.00% |
| Charles Schwab Investment Management Inc | 61,424 | $789.9K | 0.00% |
| Cubist Systematic Strategies, LLC | 37,861 | $486.9K | 0.01% |
| SG Americas Securities, LLC | 33,666 | $433.0K | 0.00% |
| Jump Financial, LLC | 27,782 | $357.3K | 0.01% |
| Alpine Global Management, LLC | 22,648 | $291.3K | 0.05% |
| Alps Advisors Inc | 19,989 | $257.1K | 0.00% |
| Corebridge Financial, Inc. | 12,419 | $159.8K | 0.00% |
| Deutsche Bank AG | 9,303 | $119.6K | 0.00% |
| New York State Common Retirement Fund | 9,300 | $119.6K | 0.00% |
| Royal Bank of Canada | 2,440 | $31.0K | 0.00% |
| Ameritas Investment Partners, Inc. | 2,262 | $29.1K | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 766 | $10.1K | 0.00% |
| Amalgamated Bank | 799 | $10.0K | 0.00% |
| CWM, LLC | 9 | $0 | 0.00% |
Sold out (31)
Institutions that held Tourmaline Bio, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
Not filed for Q2 2024 yet (1)
Institutions that held Tourmaline Bio, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Credit Suisse AG | 18,715 | $428.6K |